Page last updated: 2024-10-22

albuterol and Cardiomyopathy, Hypertrophic

albuterol has been researched along with Cardiomyopathy, Hypertrophic in 4 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research Excerpts

ExcerptRelevanceReference
"Albuterol aerosol was an effective bronchodilator as reflected by indices of pulmonary function obtained from spirometry and flow volume curves; Compared with isoproterenol, there were minimal side effects even at the highest doses, and bronchodilation lasted significantly longer."2.64Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols. ( Garza Gomez, M; Spector, SL, 1977)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19903 (75.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meyer, MF1
Hopkins, WE1
Kaminsky, DA1
Yukawa, T1
Numao, T1
Motojima, S1
Fukuda, T1
Ikemori, R1
Makino, S1
Shimizu, T1
Hayashi, T1
Smith, SC1
Spector, SL2
Garza Gomez, M1

Trials

1 trial available for albuterol and Cardiomyopathy, Hypertrophic

ArticleYear
Dose-response effects of albuterol aerosol compared with isoproterenol and placebo aerosols: response to albuterol, isoproterenol, and placebo aerosols.
    The Journal of allergy and clinical immunology, 1977, Volume: 59, Issue:4

    Topics: Adolescent; Adult; Aerosols; Aged; Albuterol; Asthma; Bronchi; Cardiomyopathy, Hypertrophic; Clinica

1977

Other Studies

3 other studies available for albuterol and Cardiomyopathy, Hypertrophic

ArticleYear
Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment.
    Chest, 2003, Volume: 124, Issue:3

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Asthma; Bronchodilator Agents

2003
[Effective combined therapy of selective beta 1-adrenergic antagonist and selective beta 2-adrenergic agonist in a patient with bronchial asthma and hypertrophic cardiomyopathy].
    Nihon Kyobu Shikkan Gakkai zasshi, 1984, Volume: 22, Issue:4

    Topics: Albuterol; Asthma; Cardiomyopathy, Hypertrophic; Drug Therapy, Combination; Female; Humans; Metoprol

1984
Cardio-selective beta-adrenergic therapy in a patient with asthma and hypertrophic obstructive cardiomyopathy.
    Chest, 1981, Volume: 80, Issue:1

    Topics: Adult; Albuterol; Asthma; Cardiomyopathy, Hypertrophic; Female; Heart; Humans; Male; Pindolol

1981